Inventor · disambiguated record
Rita L. Wong
Also filed as: WONG RITA L
15 granted patents·9 pending applications·1,810 citations·filing 1998–2024
95Inventor score
Top patents by PatentIndex Score
24 records- 0197US12098211B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2023·Granted Sep 24, 2024·2 cites·14 claims
- 0297US11999791B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2023·Granted Jun 4, 2024·6 cites·43 claims
- 0397US11987638B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted May 21, 2024·4 cites·30 claims
- 0497US11976127B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2023·Granted May 7, 2024·4 cites·28 claims
- 0597US11639395B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted May 2, 2023·8 cites·17 claims
- 0697US11078294B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted Aug 3, 2021·11 cites·8 claims
- 0797US10906986B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted Feb 2, 2021·12 cites·9 claims
- 0897US10808037B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted Oct 20, 2020·13 cites·9 claims
- 0997US10759866B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2019·Granted Sep 1, 2020·13 cites·9 claims
- 1097US6171586B1Antibody formulationGENENTECH INC·Filed 1998·Granted Jan 9, 2001·1.6k cites·29 claims
- 1196US12173080B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted Dec 24, 2024·1 cites·10 claims
- 1296US12145997B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted Nov 19, 2024·1 cites·8 claims
- 1396US11987637B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted May 21, 2024·1 cites·30 claims
- 1495US8574869B2Prevention of disulfide bond reduction during recombinant production of polypeptidesKAO YUNG-HSIANG·Filed 2012·Granted Nov 5, 2013·37 cites·10 claims
- 1595US6991790B1Antibody formulationGENENTECH INC·Filed 2000·Granted Jan 31, 2006·104 cites·20 claims
- 1693US2025243291A1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Application pending·0 cites
- 1767US2017313780A1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2017·Application pending·0 cites
- 1867US2009053786A1Prevention of disulfide bond reduction during recombinant production of polypeptidesKAO YUNG-HSIANG·Filed 2008·Application pending·0 cites
- 1966US2014128575A1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2013·Application pending·0 cites
- 2049US2005158316A1Antibody formulationGENENTECH INC·Filed 2005·Application pending·0 cites
- 2148US2014308270A1Method and formulation for reducing aggregation of a macromolecule under physiological conditionsGENENTECH INC·Filed 2013·Application pending·0 cites
- 2247US2014093493A1Method and formulation for reducing aggregation of a macromolecule under physiological conditionsGENENTECH INC·Filed 2013·Application pending·0 cites
- 2341US2011300135A1Method and formulation for reducing aggregation of a macromolecule under physiological conditionsLOBO BRIAN·Filed 2011·Application pending·0 cites
- 2441US2011305639A1Method and formulation for reducing aggregation of a macromolecule under physiological conditionsLOBO BRIAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rita L. Wong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →